TheodoreSamuelJohnsonMD
Pediatric Hematology & Oncology • Augusta, GAAssistant Professor, Pediatrics, Medical College of Georgia at Georgia Health Sciences University
Are you Dr. Johnson?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 44 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1120 15th St
# CN-4141A
Augusta, GA 30912Phone+1 706-721-3626Fax+1 706-721-4804
Summary
- Dr. Theodore Johnson, MD is a pediatric hematologist/oncologist in Augusta, Georgia. He is currently licensed to practice medicine in Georgia, Ohio, and South Carolina. He is affiliated with WellStar MCG Health, affiliated with Medical College of Georgia and is an Assistant Professor at Medical College of Georgia at Georgia Health Sciences University.
Education & Training
Cincinnati Children's Hospital Medical CenterFellowship, Pediatric Hematology/Oncology, 2007 - 2010
Medical College of GeorgiaResidency, Pediatrics, 2004 - 2007- Medical College of Georgia at Augusta UniversityClass of 2004
Certifications & Licensure
GA State Medical License 2010 - 2026
SC State Medical License 2006 - 2017
OH State Medical License 2007 - 2012- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Safety and Effectiveness of Cord Blood Stem Cell Infusion for the Treatment of Cerebral Palsy in Children Start of enrollment: 2010 Jan 01
- Pediatric Trial of Indoximod With Chemotherapy and Radiation for Relapsed Brain Tumors or Newly Diagnosed DIPG Start of enrollment: 2019 Oct 02
Publications & Presentations
PubMed
- 11 citationsIndoximod-based chemo-immunotherapy for pediatric brain tumors: A first-in-children phase I trial.Theodore S Johnson, Tobey J MacDonald, Rafal Pacholczyk, Dolly Aguilera, Ahmad Al-Basheer
Neuro-Oncology. 2024-02-02 - 45 citationsInhibition of the BTK-IDO-mTOR axis promotes differentiation of monocyte-lineage dendritic cells and enhances anti-tumor T cell immunityMadhav D. Sharma, Rafal Pacholczyk, Huidong Shi, Zuzana Berrong, Yousef Zakharia
Immunity. 2021-10-12 - 61 citationsTreg Destabilization and Reprogramming: Implications for Cancer ImmunotherapyDavid H. Munn, Madhav D. Sharma, Theodore S. Johnson
Cancer Research. 2018-09-15
Press Mentions
- Novel Immunotherapy Beneficial to Children with Relapsed Brain Tumours: ResearchApril 25th, 2023
- Novel Treatment Regimen Appears Well Tolerated, Beneficial to Children with Relapsed Brain TumorsApril 25th, 2023
